Stay updated with breaking news from Fim Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
27.10.2023 - Positive aggregate safety data from vafidemstat's fully enrolled PORTICO Phase IIb trial in Borderline Personality Disorder (BPD), consistent with safety data from seven completed clinical trials, supporting the drug is safe and ...
24 July 2023 ORYZON reports financial results and corporate updates for half-year ending June 30, 2023 Positive aggregate safety data from...
24.07.2023 - Positive aggregate safety data from vafidemstat's PORTICO Phase IIb trial in Borderline Personality Disorder (BPD), consistent with safety data from seven completed clinical trials, supporting the drug is safe and well-toleratedContinues to enroll ...
27 June 2023 ORYZON Announces Voting Results from its 2023 Annual General Meeting of Shareholders All resolutions were approved. 35% of the issued shares represented. ...
BioEquity Europe 2023Foro Medcap BME 2023 VI Ibero-American Congress CEAPI 2023BIO International Conference 2023Jefferies Healthcare Conference 2023MidCap Paris 2023 MADRID and BOSTON, May 09, 2023 ... | May 9, 2023